Table 2

Affinity (Ki) values for the inhibition of [3H]diprenorphine binding by naloxone or naltriben in the absence or presence of GppNHp/NaCl to membranes prepared from opioid naı̈ve, morphine, or DPDPE-pretreated GH3DORT8 cells

Acute DrugChronic PretreatmentKiKiH/KiLRatio
−GppNHp/NaCl (High)+GppNHp/NaCl (Low)
nM
NaloxoneNone67.1  ± 4.912.4  ± 0.97** 5.5  ± 0.25
Morphine69.2  ± 2.711.3  ± 2.4** 6.5  ± 1.0
DPDPE61.6  ± 5.35.3  ± 1.4** 13.4  ± 3.52-a
NaltribenNone0.23  ± 0.040.15  ± 0.031.6  ± 0.09
Morphine0.19  ± 0.020.11  ± 0.031.9  ± 0.3
DPDPE0.22  ± 0.070.036  ± 0.012-150 8.2  ± 2.2b

The displacement of [3H]diprenorphine binding by nalxone or naltriben to membranes prepared from opioid naı̈ve, and morphine- or DPDPE-pretreated GH3DORT8 cells was determined. Cells were treated with or without 20 μM morphine or 1 μM DPDPE for 48 h. Membranes were prepared from extensively washed cells as described under Materials and Methods. Competition binding was determined with 1 nM [3H]diprenorphine and increasing concentrations of naloxone or naltriben in the presence or absence of 25 μM GppNHp and 100 mM NaCl. Affinity (Ki) values are expressed as mean ± S.E.M and were calculated from IC50 values derived from complete concentration-effect curves. The Kd values for [3H]diprenorphine in GH3DORT8 membranes used to calculate the presentedKi values were obtained from Martin et al. (2002) and are 0.71 ± 0.04 nM (−GppNHp/NaCl) and 1.06 ± 0.14 nM (+GppNHp/NaCl). Results are presented as the mean ± S.E.M. from three to six experiments performed in triplicate.

  • 2-150 and ** Significantly different from corresponding (high)Ki value (* P < 0.05, ** P < 0.01; Student's t test).

  • 2-a and b Significantly different from correspondingKiH/KiL ratio in cells receiving no chronic pretreatment (a P < 0.05, b P < 0.007; one-way ANOVA plus Dunnett's post hoc test).